FindTrial
Sign In

Association of Cytochrome P-450 Polymorphism with adverse clinical outcomes among Patients with Ischemic Stroke: Pragmatic and Preliminary study

Association of Cytochrome P-450 Polymorphism with adverse clinical outcomes among Patients with Ischemic Stroke: Pragmatic and Preliminary study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000354
Enrollment
163
Registered
2012-02-09
Start date
2010-04-05
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hallym University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Ischemic stroke survivor on clopidogrel therapy - Patients who survived a first ischemic stroke were exposed to clopidogrel in Hallym university Sacred Heart Hospital - Patients who continuously taken clopidogrel for secondary prevention of stroke 2. CYP2C19 genotyping - Patients who underwent CYP2C19 genotyping. 3. Informed consent

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
cardiovascular event (ischemic storke, hemorrhagic stroke, MI, unstable angina)—

Countries

Korea, Republic of

Contacts

Public ContactMi-Sun Oh

Hallym University Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026